ExploreWatchlistsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Total non-current liabilities

KYORIN Pharmaceutical Co., Ltd. (4569)

Market cap
¥106B
P/E ratio
19.6x
Kyorin Pharmaceutical manufactures and sells pharmaceutical products through an integrated system spanning from production to sales across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Mar 31, 202522,221+1482.69%
Mar 31, 20241,404-91.00%
Mar 31, 202315,600+2.40%
Mar 31, 202215,234+1.18%
Mar 31, 202115,057-12.06%
Mar 31, 202017,121+109.84%
Mar 31, 20198,159-17.74%
Mar 31, 20189,918+1.24%
Mar 31, 20179,797-23.00%
Mar 31, 201612,723+81.52%
Mar 31, 20157,009

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat